Latest Thrombolysis Stories
Everyone is familiar with the pain of skinned knees.
By discovering how a blood clot-busting enzyme is switched on, researchers have unlocked a century-old atomic riddle that could lead to new treatments for clotting and bleeding disorders, and some cancers.
Until now, few studies have looked into the safety of children taking the same clot-busting drugs used by adults to reduce stroke symptom disabilities.
New research looks at whether clot-busting drugs can safely be given to children who have strokes.
A recent study suggests that a new scoring method, called the DRAGON score, can help doctors determine quickly who will respond well to the drug alteplase, a clot-busting drug for stroke patients.
A new scoring method can help doctors quickly decide which stroke patients will respond well to the clot-busting drug alteplase, according to a study published in the February 7, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology.
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.
An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association’s 2012 International Stroke Conference.
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull.